Literature DB >> 2358851

Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas.

D Krouwer1, M McDermott, M Prados.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2358851

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  9 in total

1.  Treatment of grades I and II brain astrocytomas. The role of radiotherapy.

Authors:  J T Fazekas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Jul-Aug       Impact factor: 7.038

2.  Prognostic implications of the proliferative potential of low-grade astrocytomas.

Authors:  T Hoshino; L A Rodriguez; K G Cho; K S Lee; C B Wilson; M S Edwards; V A Levin; R L Davis
Journal:  J Neurosurg       Date:  1988-12       Impact factor: 5.115

3.  Cerebral hemisphere astrocytoma: treatment results.

Authors:  J Boyages; K W Tiver
Journal:  Radiother Oncol       Date:  1987-03       Impact factor: 6.280

4.  Radiation therapy in the treatment of cerebral astrocytoma.

Authors:  R A Morantz
Journal:  Neurosurgery       Date:  1987-06       Impact factor: 4.654

5.  [Indication and results of radiation therapy in the treatment of astrocytomas (author's transl)].

Authors:  C Glanzmann; J Peters; W Horst; R Friede
Journal:  Strahlentherapie       Date:  1980-06

6.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

7.  Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

Authors:  V A Levin; W M Wara; R L Davis; P Vestnys; K J Resser; K Yatsko; S Nutik; P H Gutin; C B Wilson
Journal:  J Neurosurg       Date:  1985-08       Impact factor: 5.115

8.  Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

Authors:  D F Nelson; J S Nelson; D R Davis; C H Chang; T W Griffin; T F Pajak
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

9.  Successful chemotherapy for recurrent malignant oligodendroglioma.

Authors:  J G Cairncross; D R Macdonald
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.